Synergistic Nanocellulose Implant System for Bile Duct Repair

Publication ID: 24-11857405_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Nanocellulose Implant System for Bile Duct Repair,” Published Technical Disclosure No. 24-11857405_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857405_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,405.

Summary of the Inventive Concept

The present inventive concept integrates nanocellulose-based medical implants with cutting-edge technologies like AI, IoT, blockchain, and smart materials to create a novel, more effective system for bile duct repair, offering improved precision, biocompatibility, and remote monitoring capabilities.

Background and Problem Solved

The original patent, 'Medical implant based on nanocellulose,' addressed the critical issue of biliary duct reconstruction in hepato-biliary surgery. However, the existing implant technology has limitations in terms of precise placement, real-time monitoring, and adaptability to the implant environment. The new inventive concept resolves these limitations by incorporating synergistic technologies to create a more powerful and efficient system.

Detailed Description of the Inventive Concept

The synergistic nanocellulose implant system for bile duct repair comprises a nanocellulose tube, a micro-robotic device for precise implant placement controlled by an AI algorithm, a sensor system for tracking implant performance transmitting data to a blockchain-based secure database, a smart material coating for enhanced biocompatibility, and an IoT-enabled communication system for remote monitoring and control. The AI-powered design algorithm enables personalized implant design based on patient-specific data and medical imaging.

Novelty and Inventive Step

The new claims introduce the novel combination of nanocellulose implants with AI, IoT, blockchain, and smart materials, which provides a non-obvious, synergistic solution for bile duct repair. The inventive step lies in the integration of these distinct technologies to create a more effective, efficient, and adaptable system.

Alternative Embodiments and Variations

Alternative embodiments may include varying the type of AI algorithm used, incorporating different types of sensors or smart materials, or integrating the system with other medical devices or platforms. Variations may also include adapting the system for use in other medical applications beyond bile duct repair.

Potential Commercial Applications and Market

The synergistic nanocellulose implant system has significant commercial potential in the medical device industry, particularly in the areas of hepato-biliary surgery and implantable devices. The system's advanced features and improved outcomes may attract healthcare providers, medical device manufacturers, and patients seeking more effective treatment options.

CPC Classifications

Section	Class	Group
A	A61	A61F2/04
A	A61	A61L31/005
A	A61	A61L31/10
A	A61	A61L31/146
A	A61	A61F2002/041
A	A61	A61L2400/12
A	A61	A61L2420/08
C	C08	C08L1/02

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically biomaterials and implantable medical technologies focusing on nanocellulose-based reconstructive surgical devices, with expertise in materials science, bioengineering, and minimally invasive surgical techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced degrees in bioengineering or materials science, experienced in designing medical implants, familiar with emerging technologies like AI, IoT, and smart materials, and possessing knowledge of biomaterial fabrication techniques

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies with the existing nanocellulose implant framework represents a predictable extension of known medical device innovation strategies. The core nanocellulose implant technology from the source patent provides a foundational platform that naturally invites technological augmentation through sensor systems, adaptive materials, and intelligent control mechanisms. The proposed variations represent logical technological progressions that leverage standard engineering design principles and emerging medical technology trends.

Obvious Combinations & Variations

Source Patent Element

Microbial cellulose tube with concentric layers for medical implant reconstruction

PTD Variation

AI-powered design algorithm for generating personalized implant geometries based on patient imaging data

Obviousness Reasoning

Customizing implant design through computational methods is a known technique in medical device engineering, representing a predictable application of machine learning to existing implant fabrication processes

Source Patent Element

Tubular stent for expanding microbial cellulose implant structure

PTD Variation

Smart material coating responsive to environmental changes within biological context

Obviousness Reasoning

Adaptive material technologies are well-established in biomedical engineering, representing a straightforward enhancement to existing implant structural modification techniques

Source Patent Element

Medical implant for biliary duct reconstruction

PTD Variation

IoT-enabled communication system for remote monitoring of implant performance

Obviousness Reasoning

Integrating sensor technologies and wireless monitoring into medical implants is a predictable technological progression in contemporary medical device design

Source Patent Element

Microbial cellulose tube with defined structural characteristics

PTD Variation

Blockchain-based secure database for tracking implant performance and patient data

Obviousness Reasoning

Implementing secure data management systems is a standard approach in medical technology for ensuring data integrity and patient privacy

Source Patent Element

Method of producing medical implant using template molding

PTD Variation

Micro-robotic device with AI-controlled precise placement mechanism

Obviousness Reasoning

Robotic surgical assistance and precision placement represent known technological extensions in minimally invasive surgical techniques

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857405 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed nanocellulose implant system variations obvious and lacking inventive step. The combination of known medical device technologies with emerging digital platforms represents a predictable technological progression that would be readily conceived by a skilled practitioner without requiring extraordinary innovation or non-obvious reasoning.

Original Patent Information

Patent Number	US 11,857,405
Title	Medical implant based on nanocellulose
Assignee(s)	UNIVERSITÄTSKLINIKUM JENA